These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1086 related articles for article (PubMed ID: 23596973)

  • 21. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
    Liu D; Wang L; Liu Z; Zhang C; Zhang N
    J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and biodisposition of methoxypolyethylene glycol amine-poly(DL-lactic acid) copolymer nanoparticles loaded with pyrene-ended poly(DL-lactic acid).
    Sasatsu M; Onishi H; Machida Y
    Int J Pharm; 2008 Jun; 358(1-2):271-7. PubMed ID: 18448290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable polymeric nanospheres formed by temperature-induced phase transition in a mixture of poly(lactide-co-glycolide) and poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer.
    Lee KE; Kim BK; Yuk SH
    Biomacromolecules; 2002; 3(5):1115-9. PubMed ID: 12217061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
    Li S; Wang A; Jiang W; Guan Z
    BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amphiphilic PCL-PEG-PCL copolymer addition on 5-fluorouracil release from biodegradable PCL films for stent application.
    Lu F; Lei L; Shen YY; Hou JW; Chen WL; Li YG; Guo SR
    Int J Pharm; 2011 Oct; 419(1-2):77-84. PubMed ID: 21803141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil.
    Ashour AE; Badran MM; Kumar A; Rishi AK; Yassin AE
    IEEE Trans Nanobioscience; 2016 Oct; 15(7):739-747. PubMed ID: 28029617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles.
    Mainardes RM; Khalil NM; Gremião MP
    Int J Pharm; 2010 Aug; 395(1-2):266-71. PubMed ID: 20580792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
    Nair K L; Jagadeeshan S; Nair SA; Kumar GS
    Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
    Sastre RL; Olmo R; Teijón C; Muñíz E; Teijón JM; Blanco MD
    Int J Pharm; 2007 Jun; 338(1-2):180-90. PubMed ID: 17336474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.
    Gref R; Quellec P; Sanchez A; Calvo P; Dellacherie E; Alonso MJ
    Eur J Pharm Biopharm; 2001 Mar; 51(2):111-8. PubMed ID: 11226817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin.
    Kunii R; Onishi H; Machida Y
    Eur J Pharm Biopharm; 2007 Aug; 67(1):9-17. PubMed ID: 17337172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and characterization of poly(ethylene glycol)-poly(D,L-lactide-co-glycolide) poly(ethylene glycol) tri-block co-polymers modified with collagen: a model surface suitable for cell interaction.
    Porjazoska A; Yilmaz OK; Baysal K; Cvetkovska M; Sirvanci S; Ercan F; Baysal BM
    J Biomater Sci Polym Ed; 2006; 17(3):323-40. PubMed ID: 16689018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study.
    Li D; Guo G; Fan R; Liang J; Deng X; Luo F; Qian Z
    Int J Pharm; 2013 Jan; 441(1-2):365-72. PubMed ID: 23178216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
    Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
    Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release.
    Rietscher R; Czaplewska JA; Majdanski TC; Gottschaldt M; Schubert US; Schneider M; Lehr CM
    Int J Pharm; 2016 Mar; 500(1-2):187-95. PubMed ID: 26784983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.